Company profile: Isomorphic Labs
1.1 - Company Overview
Company description
- Provider of AI-driven drug discovery and development solutions, delivering machine-learning platforms that analyze biological data to identify drug candidates, help researchers understand complex biology, and predict compound effects. Engages in strategic collaborations with pharmaceutical companies and advances digital biology research, building on innovations like AlphaFold.
Products and services
- Partnerships for Pharmaceutical Development: AI-enabled collaborations with pharmaceutical companies that apply the platform’s technology to architect drug design and discovery programs, leveraging biological data analyses for candidate identification
- AI-driven Drug Discovery Platform: A machine-learning-based system that analyzes biological data, builds upon AlphaFold, identifies potential drug candidates, and assists researchers in understanding complex biological systems and predicting compound effects
- Research in Digital Biology: Computational research initiatives that apply AI and advanced methods to biological datasets for drug discovery, expanding understanding of complex biological systems and effects of various compounds
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Isomorphic Labs
Faculty Opinions
HQ: United Kingdom
Website
- Description: Provider of a discovery tool for qualitative assessment of published research, leveraging a faculty of over 8,000 leading life science and medicine experts who comment on and validate key publications. Offers H1 Connect for global health opportunities and training, H1 Profile to build credibility and apply, and a WhatsApp community for global peer collaboration.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Faculty Opinions company profile →
Integrated Proteomics
HQ: United States
Website
- Description: Provider of a comprehensive proteomic data analysis solution, the Integrated Proteomics Pipeline (IP2), designed to make proteomics data analysis easy and streamlined for universities, research hospitals, pharmaceutical companies, and biological research institutes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Integrated Proteomics company profile →
TargetRx
HQ: United States
Website
- Description: Provider of unique insights for pharmaceutical and biotech companies into the true drivers of product choice and adoption for their brands, enabling confident actions to grow businesses and help patients, with a suite of solutions spanning from pipeline through patent expiry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TargetRx company profile →
Prelude Dynamics
HQ: United States
Website
- Description: Provider of innovative software for human and veterinary clinical trials, including VISION, the only Clinical Trial Optimization Platform (CTOP) available in the industry. Offerings include a web-based EDC for compliant data collection, an ePRO mobile app for participant data entry, and professional services with Customer Success Managers for study design and implementation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Prelude Dynamics company profile →
MedAvante-ProPhase
HQ: United States
Website
- Description: Provider of technology-enabled signal detection solutions in clinical trials of treatments for nervous system disorders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MedAvante-ProPhase company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Isomorphic Labs
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Isomorphic Labs
2.2 - Growth funds investing in similar companies to Isomorphic Labs
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Isomorphic Labs
4.2 - Public trading comparable groups for Isomorphic Labs
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →